Related Party Transactions

12 Months Ended

Dec. 31, 2021

Related Party Transactions [Abstract]

Related Party Transactions

20. Related Party Transactions

As of December 31, 2021, Vifor owned 7,396,770, or 13.8%, of the Company’s common stock. Both Vifor and VFMCRP are considered related parties as of December 31, 2021 (see Note 12, Collaboration and Licensing Agreements).

Sales of KORSUVA injection to Vifor for $701 were included within Commercial supply revenue on the Company’s Statement of Comprehensive (Loss) Income for the year ended December 31, 2021. Sales of clinical compound to VFMCRP for $361 were included within Clinical compound revenue on the Company’s Statement of Comprehensive (Loss) Income for the year ended December 31, 2021.